48.40MMarket Cap-737P/E (TTM)
1.000High0.920Low221.07KVolume1.000Open0.950Pre Close207.81KTurnover1.29%Turnover RatioLossP/E (Static)52.11MShares1.85052wk High-1.49P/B15.96MFloat Cap0.63052wk Low--Dividend TTM17.19MShs Float13.520Historical High--Div YieldTTM8.42%Amplitude0.630Historical Low0.940Avg Price1Lot Size
Lucid Diagnostics Stock Forum
PR Newswire· 2 mins ago
NEWS
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing
The peer-reviewed publication of positive data from a National Cancer Institute-sponsored study enhances Lucid Diagnostics' reputation and credibility in the medical diagnostics field.
EsoGuard's demonstration of unprecedented early precancer detection with 89...
Non-GAAP net loss for the quarter was $9.9 million, showing a slight increase from Q3 but a year-over-year decrease of $700,000.
The company had a year-end cash balance of $18.9 million, supported by a recent financing of $18.1 million.
Approximately 50% of the claims submitted have been adjudicated, with an averaging payment of $1,800.
The projected re...
PR Newswire· 1 min ago
The World Trade Center Health Program will now cover the cost of EsoGuard testing for its more than 120,000 participants at almost 2.5K per billable test
Dow Jones· 1 min ago
By Danilo
$InnovAge Holding(INNV.US)$ $Lucid Diagnostics(LUCD.US)$ $Innovid(CTV.US)$ $Chesapeake Energy(CHK.US)$
No comment yet